MetaADEDB 2.0 @ LMMD
elagolix
(HEAUOKZIVMZVQL-VWLOTQADSA-N)
Structure
SMILES
COc1cccc(c1F)c1c(=O)n(C[C@@H](c2ccccc2)NCCCC(=O)O)c(=O)n(c1C)Cc1c(F)cccc1C(F)(F)F
Type(s)
Approved; Investigational
Molecular Formula:
C32H30F5N3O5
Molecular Weight:
631.590
Log P:
5.9259
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
102.56
CAS Number(s):
834153-87-6
Synonym(s)
1.
elagolix
2.
R-(+)-4-(2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl)-1-phenylethylamino)butyrate
External Link(s)
MeSHC539351
PubChem Compound11250647
CHEMBLCHEMBL1208155
DrugBankDB11979
IUPHAR/BPS Guide to PHARMACOLOGY8362
KEGGdr:D09335
Therapeutic Target DatabaseD0UI3T
ZINC49888891
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 41US FAERS
2PainFAERS: 25US FAERS
3Drug ineffectiveFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
4HeadacheFAERS: 17US FAERS
5EndometriosisFAERS: 1321657270CTD
US FAERS
6Mood swingsFAERS: 12US FAERS
7ArthralgiaFAERS: 11US FAERS
8AnxietyFAERS: 10US FAERS
9FatigueFAERS: 10US FAERS
10MenorrhagiaFAERS: 9US FAERS
11VomitingFAERS: 9US FAERS
12DizzinessFAERS: 8US FAERS
13UrticariaFAERS: 7US FAERS
14CryingFAERS: 6US FAERS
15Feeling abnormalFAERS: 6US FAERS
16Night sweatsFAERS: 6US FAERS
17Pelvic PainFAERS: 5US FAERS
18Abdominal PainFAERS: 4US FAERS
19AcneFAERS: 4US FAERS
20Adverse eventFAERS: 4US FAERS
21Chest PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Emotional disorderFAERS: 4US FAERS
23MetrorrhagiaFAERS: 4US FAERS
24Product dose omissionFAERS: 4US FAERS
25AlopeciaFAERS: 3US FAERS
26Back PainFAERS: 3US FAERS
27DyspepsiaFAERS: 3US FAERS
28HysterectomyFAERS: 3US FAERS
29Vulvovaginal drynessFAERS: 3US FAERS
30Abdominal discomfortFAERS: 2US FAERS
31AngerFAERS: 2US FAERS
32ConstipationFAERS: 2US FAERS
33CystFAERS: 2US FAERS
34DyspareuniaFAERS: 2US FAERS
35Emotional distressFAERS: 2US FAERS
36Intentional product misuseFAERS: 2US FAERS
37Musculoskeletal PainFAERS: 2US FAERS
38PalpitationsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Product dispensing errorFAERS: 2US FAERS
40SomnolenceFAERS: 2US FAERS
41TachycardiaFAERS: 2US FAERS
42TremorFAERS: 2US FAERS
43Urge IncontinenceFAERS: 2US FAERS
44Altered state of consciousnessFAERS: 1US FAERS
45AnorgasmiaFAERS: 1US FAERS
46ArthritisFAERS: 1US FAERS
47AuraFAERS: 1US FAERS
48Bone painFAERS: 1US FAERS
49Carpal Tunnel SyndromeFAERS: 1US FAERS
50Cerebrovascular accidentFAERS: 1US FAERS
51Chest discomfortFAERS: 1US FAERS
52DehydrationFAERS: 1US FAERS
53Depressed moodFAERS: 1US FAERS
54Endometrial thickeningFAERS: 1US FAERS
55EpilepsyFAERS: 1US FAERS
56Feeling ColdFAERS: 1US FAERS
57FibromyalgiaFAERS: 1US FAERS
58Gastrointestinal motility disorderFAERS: 1US FAERS
59General symptomFAERS: 1US FAERS
60Head discomfortFAERS: 1US FAERS
61HerniaFAERS: 1US FAERS
62Hormone level abnormalFAERS: 1US FAERS
63HypersensitivityFAERS: 1US FAERS
64Inadequate analgesiaFAERS: 1US FAERS
65Inappropriate schedule of product administrationFAERS: 1US FAERS
66Inflammatory marker increasedFAERS: 1US FAERS
67Insurance issueFAERS: 1US FAERS
68Intentional self-injuryFAERS: 1US FAERS
69Intestinal ObstructionFAERS: 1US FAERS
70Joint swellingFAERS: 1US FAERS
71MalaiseFAERS: 1US FAERS
72Medication ErrorFAERS: 1US FAERS
73Memory impairmentFAERS: 1US FAERS
74Muscle enzyme increasedFAERS: 1US FAERS
75Musculoskeletal chest painFAERS: 1US FAERS
76Musculoskeletal stiffnessFAERS: 1US FAERS
77MyalgiaFAERS: 1US FAERS
78NasopharyngitisFAERS: 1US FAERS
79Ovulation disorderFAERS: 1US FAERS
80Partner stressFAERS: 1US FAERS
81Pelvic adhesionsFAERS: 1US FAERS
82Personality ChangeFAERS: 1US FAERS
83Physical assaultFAERS: 1US FAERS
84Premature MenopauseFAERS: 1US FAERS
85Product use complaintFAERS: 1US FAERS
86Product use in unapproved indicationFAERS: 1US FAERS
87PruritusFAERS: 1US FAERS
88RetchingFAERS: 1US FAERS
89RosaceaFAERS: 1US FAERS
90Salpingo-oophorectomy unilateralFAERS: 1US FAERS
91ScreamingFAERS: 1US FAERS
92StressFAERS: 1US FAERS
93Suicide attemptFAERS: 1US FAERS
94Suspected suicide attemptFAERS: 1US FAERS
95SwellingFAERS: 1US FAERS
96Throat irritationFAERS: 1US FAERS
97ThrombosisFAERS: 1US FAERS
98ToothacheFAERS: 1US FAERS
99Unevaluable eventFAERS: 1US FAERS
100Vulvovaginal swellingFAERS: 1US FAERS
101Weight decreasedFAERS: 1US FAERS
102colonoscopyFAERS: 1US FAERS
103jaundiceFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.